Clinical Trial Update: CTA-MCI: Cognitive Control Training in Patients With Amnestic Mild Cognitive Impairment(CTA-MCI) [NA]

View source ↗

Summary

CTA-MCI is a clinical trial evaluating cognitive control training in individuals with amnestic mild cognitive impairment. The sponsor is the First Affiliated Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amnestic Mild Cognitive Impairment

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Amnestic Mild Cognitive Impairment | NA | Status: UNKNOWN